Franco Folli

About Franco Folli

Franco Folli, With an exceptional h-index of 75 and a recent h-index of 39 (since 2020), a distinguished researcher at Università degli Studi di Milano, specializes in the field of Internal Medicine, obesity, diabetes, autoimmunity.

His recent articles reflect a diverse array of research interests and contributions to the field:

Hyperglycemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in islets of Langerhans: implications for type 2 diabetes pathogenesis

Drug–Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4-and CYP2D6-Mediated Metabolism

Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLD

Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide

Alanine transferase levels (ALT) and triglyceride-glucose index are risk factors for type 2 diabetes mellitus in obese patients

Delayed puberal development in obese males: possible role of hypogonadotropic hypogonadism

Obesity effect on newly diagnosed and recurrent post-ablation atrial fibrillation: a systematic review and meta-analysis

Mechanisms of action of incretin receptor based dual-and tri-agonists in pancreatic islets

Franco Folli Information

University

Position

Department of Health Science; Endocrinology and Metabolism - ASST Santi Paolo

Citations(all)

27717

Citations(since 2020)

6789

Cited By

23288

hIndex(all)

75

hIndex(since 2020)

39

i10Index(all)

179

i10Index(since 2020)

125

Email

University Profile Page

Google Scholar

Franco Folli Skills & Research Interests

Internal Medicine

obesity

diabetes

autoimmunity

Top articles of Franco Folli

Hyperglycemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in islets of Langerhans: implications for type 2 diabetes pathogenesis

American Journal of Physiology-Endocrinology and Metabolism

2024/5/1

Drug–Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4-and CYP2D6-Mediated Metabolism

Drugs in R&D

2023/11/27

Franco Folli
Franco Folli

H-Index: 40

Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLD

Digestive and Liver Disease

2024/2/1

Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide

Pharmacological Research

2024/1/1

Alanine transferase levels (ALT) and triglyceride-glucose index are risk factors for type 2 diabetes mellitus in obese patients

Acta Diabetologica

2023/12/6

Franco Folli
Franco Folli

H-Index: 40

Delayed puberal development in obese males: possible role of hypogonadotropic hypogonadism

2023/11/24

Obesity effect on newly diagnosed and recurrent post-ablation atrial fibrillation: a systematic review and meta-analysis

2023/11/14

Mechanisms of action of incretin receptor based dual-and tri-agonists in pancreatic islets

2023/11/1

Multiple beneficial effects of 1-year nutritional–behavioral intervention on anthropometric and metabolic parameters in overweight and obese boys

Journal of Endocrinological Investigation

2023/11

Effetti benefici sui parametri antropometrici e metabolici nei ragazzi sovrappeso e obesi dopo 1 anno di intervento nutrizionale-comportamentale

2023/10/20

Esmethadone-HCl (REL-1017): a promising rapid antidepressant

2023/10

AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus

Acta Diabetologica

2023/9

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users

Translational Psychiatry

2023/6/7

Franco Folli
Franco Folli

H-Index: 40

Stefano Comai
Stefano Comai

H-Index: 24

Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study

Cardiovascular Diabetology

2023/3/25

Giuseppe Favacchio
Giuseppe Favacchio

H-Index: 4

Franco Folli
Franco Folli

H-Index: 40

Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder

The Primary Care Companion for CNS Disorders

2023/2/14

Luca Pani
Luca Pani

H-Index: 27

Franco Folli
Franco Folli

H-Index: 40

Effect of prolonged and substantial weight loss on incident atrial fibrillation: a systematic review and meta-analysis

2023/2/14

Beneficial effects on anthropometric and metabolic parameters in overweight and obese boys after 1 year nutritional-behavioral intervention

2023

Effetti benefici su parametri antropometrici e metabolici in ragazzi in sovrappeso e obesi dopo un intervento nutrizionale-comportamentale di un anno

2023

Uno studio longitudinale sull’incidenza di eventi cardiovascolari in una popolazione del nord Italia

2022/10/14

Esmethadone (REL-1017) and other uncompetitive NMDAR channel blockers may improve mood disorders via modulation of synaptic kinase-mediated signaling

International Journal of Molecular Sciences

2022/10/13

Luca Pani
Luca Pani

H-Index: 27

Franco Folli
Franco Folli

H-Index: 40

See List of Professors in Franco Folli University(Università degli Studi di Milano)

Co-Authors

academic-engine